SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000912057-02-001426
Filing Date
2002-01-15
Accepted
2002-01-15 00:00:00
Documents
9
Effectiveness Date
2002-01-15

Document Format Files

Seq Description Document Type Size
1 FORM S-8 a2067525zs-8.txt S-8 28648
3 EXHIBIT 5 a2067525zex-5.txt EX-5 1840
4 EXHIBIT 23.1 a2067525zex-23_1.txt EX-23.1 1015
5 EXHIBIT 23.2 a2067525zex-23_2.txt EX-23.2 785
6 EXHIBIT 23.3 a2067525zex-23_3.txt EX-23.3 815
7 EXHIBIT 23.4 a2067525zex-23_4.txt EX-23.4 632
8 EXHIBIT 23.5 a2067525zex-23_5.txt EX-23.5 523
9 EXHIBIT 23.6 a2067525zex-23_6.txt EX-23.6 532
10 EXHIBIT 23.7 a2067525zex-23_7.txt EX-23.7 678
  Complete submission text file 0000912057-02-001426.txt   37848
Mailing Address ONE KENDALL SQUARE CAMBRIDGE MA 02139
Business Address ONE KENDALL SQ CAMBRIDGE MA 02139 6172527500
GENZYME CORP (Filer) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-76766 | Film No.: 2509884
SIC: 2836 Biological Products, (No Diagnostic Substances)